ArticleJournal for immunotherapy of cancer2026

Genetically engineered ErbB2 overexpression sensitizes organoid-derived tumors to checkpoint inhibition in a syngeneic model of gastric cancer.

Jiazhuo He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.